The increasing interest in psychedelic investment opportunities, including some recent developments in China, has led some analysts to begin studying the psychedelic patent landscape. Given the relatively small amount of …
** See also recent article on “Investing in Psychedelics – a 2020 Perspective” ** [Updated December 2019] Are magic mushrooms (or psilocybin) going to be the next big investment opportunity …
On April 05, 2019, Wuhan General Group, Inc. announced that its subsidiary MJ MedTech, Inc. (MJ MedTech) has created a new division dedicated to exploring opportunities in the psychedelic medicine …
Recent developments in science and policy reform suggest that “magic mushrooms” and psilocybin technology will evolve into a psilocybin industry. Investments by several early movers illustrate that a psilocybin industry …
The molecule Psilacetin (aka 4-AcO-DMT or O-Acetylpsilocin) is a synthetic psilocybin derivative. Like psilocybin, psilacetin serves as a prodrug of psilocin, which is the primary active molecule responsible for the …
Several organizations in the United States and worldwide are seeking to legalize or decriminalize “magic mushrooms” (the organism) and/or psilocybin (the molecule). At a high level, these two approaches represent …
The National Hockey League Alumni Association (herein “NHLAA”) recently entered into a partnership with Canopy Growth Company (“CGC” or “Canopy”). The Canopy-NHLAA collaboration will focus on exploring cannabis-based neurological treatments …
All signs point to the rise of psilocybin technology. This raises questions regarding the size of the future psilocybin industry. How much will psilocybin products cost consumers? How much will …
Madison Margolin recently published an article in Rolling Stone Magazine explaining that the future of cannabis technology will center around formulated products that eliminate the inherent variability of natural cannabis. …
Best-selling author, entrepreneur, and angel investor Tim Ferriss praises the benefits of psychedelics. Mr. Ferriss financially supports psychedelic research and he methodically uses psychedelics for treating depression and enhancing cognition. …
